Медицинский вестник Юга России (Sep 2019)

Safety and efficiency of using Omaulizumab in bronchial asthma

  • E. A. Strel’tsov,
  • V. S. Demidov,
  • L. V. Tsoy,
  • M. E. Korovina,
  • N. M. Razyschikova,
  • А. E. Karzhauova

DOI
https://doi.org/10.21886/2219-8075-2019-10-2-6-12
Journal volume & issue
Vol. 10, no. 2
pp. 6 – 12

Abstract

Read online

This review reviews the efficacy and safety of omalizumab therapy in bronchial asthma using randomized trials of recent years. Mechanisms of the pathogenesis of bronchial asthma, the effectiveness of the drug and its side effects are discussed in detail. The effectiveness of omalizumab is considered at the following key research points: the need for inhaled glucocorticosteroids, the quality of patients’ life and the frequency of exacerbations. Systematic literature search was carried out on the databases Scopus, Web of Science, MedLine, elibrary and others.

Keywords